RV3-BB neonatal rotavirus vaccine trial
Liverpool, United Kingdom
Clinical dose-ranging trial of a neonatal rotavirus vaccine RV3-BB in Malawi, led by Murdoch Children's Research Institute, University of Melbourne, in collaboration with Centre for Global Vaccine Research, University of Liverpool, UK and the Malawi-Liverpool-Wellcome Trust Clinical Research Programme in Blantyre, Malawi.
- Start Date:
- End Date: